Table 3. Prevalence of Hypomagnesaemia in Patients with Type 2 Diabetes according to the Relevant Demographic and Clinical Characteristics (N = 1105).
Variable | Hypomagnesaemia, No. (%) | P Value |
---|---|---|
Age, y | - | 0.109 |
<50 | 37 (14.7) | - |
50-59 | 74 (19.3) | - |
≥ 60 | 99 (21.1) | - |
Gender | - | 0.000001 |
Male | 65 (12.2) | - |
Female | 145 (25.3) | - |
Smoking | - | 0.002 |
Non | 171 (21.0) | - |
Past | 19(17.3) | - |
Current | 20 (11.0) | - |
Duration of Diabetes, y | - | 0.00001 |
<5 | 53 (11.9) | - |
5-9 | 63 (24.3) | - |
≥ 10 | 94 (23.4) | - |
Hypertension | - | 0. 000001 |
Yes | 176 (22.4) | |
No | 34 (10.6) | |
Dyslipidemia | - | 0.022 |
Yes | 171 (20.6) | - |
No | 39 (14.3) | - |
Retinopathy | - | 0.220 |
Yes | 55 (21.7) | - |
No | 155 (18.2) | - |
Neuropathy | - | 0.263 |
Yes | 87 (17.5) | - |
No | 123 (20.2) | - |
HbA1c, % | - | 0.001 |
< 7 | 51 (13.0) | - |
7-7.9 | 73 (24.5) | - |
8-8.9 | 37 (19.4) | - |
≥ 9 | 49 (22.0) | - |
Patients on loop diuretics | - | 0.010 |
Yes | 16 (33.3) | - |
No | 194 (18.4) | - |
Patients on thiazide diuretics | - | 0.007 |
Yes | 59 (25.1) | - |
No | 151 (17.4) | - |
Patients on statin | - | 0.000059 |
Yes | 149 (22.9) | - |
No | 61 (13.5) | - |